ArticleJournal of experimental & clinical cancer research : CR2026
CDK4-selective inhibitor AU2-94 for the treatment of advanced and therapy-resistant prostate cancer.
Ava Safaroghli-Azar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.